Conversion from trough (C0) to 2 hour (C2) monitoring of cyclosporine level in pediatric heart transplant patients - An intent-to-treat study

被引：0
|
作者：
Canter, C. E. [1 ]
Hmiel, S. P. [1 ]
Shepherd, R. W. [1 ]
Lassa-Claxton, S. A. [1 ]
Landt, M. [1 ]
机构：
[1] Washington Univ, St Louis, MO USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2005年 / 24卷 / 02期
关键词：
D O I：
10.1016/j.healun.2004.11.307
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
284
引用
收藏
页码：S135 / S135
页数：1
相关论文
共 50 条
  • [1] Conversion from trough (C0) to 2 hour (C2) monitoring of cyclosporine in pediatric heart transplant recipients - an intent to treat analysis.
    Canter, CE
    Hmiel, SP
    Shepherd, RW
    Lassa-Claxton, SA
    Landt, ML
    PEDIATRIC TRANSPLANTATION, 2005, 9 : 51 - 51
  • [2] Calculated AUC versus cyclosporine C0 and C2 level monitoring in pediatric renal transplant patients.
    Baskin, E
    Agras, PI
    Saatci, U
    Karakayali, H
    Yucel, M
    Haberal, M
    PEDIATRIC TRANSPLANTATION, 2005, 9 : 99 - 99
  • [3] Assessment of cyclosporine pharmacokinetic parameters to facilitate conversion from C0 to C2 monitoring in heart transplant recipients
    Davies, R. A.
    Veinot, J. P.
    Williams, K.
    Haddad, H.
    Baker, A.
    Donaldson, J.
    Pugliese, C.
    Struthers, C.
    Masters, R. G.
    Hendry, P. J.
    Mesana, T.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (10) : 3334 - 3339
  • [4] Trough (C0) and 2-hour postdose (C2) cyclosporine monitoring in patients with moderate-to-severe psoriasis
    Herrero-Moyano, M.
    Pedraz, J.
    Munoz-Aceituno, E.
    Chicharro, P.
    Reolid, A.
    Lara, S.
    Dauden, E.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (05) : E215 - E217
  • [5] Observational study on the conversion from C0 to C2 monitoring of cyclosporine (Neoral) in stable liver transplant recipients
    Situmorang, G
    Jones, R
    Berry, R
    Fink, M
    Wang, BZ
    Gow, P
    Angus, P
    IMMUNOLOGY AND CELL BIOLOGY, 2004, 82 (02): : A22 - A22
  • [6] C2 and C0 values for monitoring cyclosporine therapy in stable heart transplant recipients
    Diciolla, F
    Scolletta, S
    Berti, L
    Maccherini, M
    Federici, D
    Bernazzali, S
    Lisi, G
    Chiavarelli, M
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 1355 - 1359
  • [7] Impact of late conversion from C0 to C2 monitoring of microemulsified cyclosporine in pediatric living donor liver transplant recipients
    Takatsuki, M
    Chen, CL
    Chen, YS
    Wang, CC
    Lin, CC
    Yang, CH
    Yong, CC
    Liu, YW
    CLINICAL TRANSPLANTATION, 2004, 18 (06) : 694 - 699
  • [8] Cyclosporine monitoring in renal transplant recipients with induction therapy:: C2 levels in patients monitored on C0
    Loichot, C
    Bentue-Ferrer, D
    Bernard, N
    Bonardet, A
    Boulieu, R
    Kergueris, MF
    Paintaud, G
    Peytavin, G
    Simon, N
    Marquet, P
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2006, 20 (01) : 91 - 96
  • [9] C2 versus C0 cyclosporine monitoring:: The end for us
    Bîrsan, T
    Wekerle, T
    Steininger, R
    Mühlbacher, F
    TRANSPLANTATION, 2005, 80 (04) : 543 - 544
  • [10] C0/C2 cyclosporine levels monitoring in renal transplantation
    Santana, A
    Guerra, J
    Milhomens, C
    Neves, F
    Prata, MM
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (03) : 1072 - 1073
12345